Sai Parenterals Limited

New PositionQuarterly

SAIPARENTPharmaceuticalsMarket Cap₹2K Cr

Stake

1.17%

Morgan Stanley

Foreign Investor

The move

Morgan Stanley acquired 514,798 shares, a 1.17% stake in Sai Parenterals Limited, valued at approximately ₹28.6 Cr. Morgan Stanley Asia (Singapore) Pte Ltd was an anchor investor in the Sai Parenterals IPO in March 2026, subscribing to shares at ₹392 apiece.

About Sai Parenterals Limited

Visit stock

A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.

About Morgan Stanley

Visit investor

US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.

Follow Morgan Stanley and Sai Parenterals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Sai Parenterals Limited shareholders Morgan Stanley's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Sai Parenterals Limited

Quant Mutual FundExited

Quant Mutual Fund, which previously held a 3.81 percent stake in Sai Parenterals Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction of its holding to below the 1 percent reporting requirement.

21 Jul 2026

Astorne CapitalExited

Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.